Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NeuroMedix

2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of therapeutic services. The company is engaged in developing therapeutic treatment for nervous and brain diseases in Toronto, Canada.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Former Stock Listing
NMX
Primary Office
  • MaRS Centre, Heritage Building
  • 101 College Street, Suite 335
  • Toronto, Ontario M5G 1L7
  • Canada

NeuroMedix Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore NeuroMedix‘s full profile, request access.

Request full access to PitchBook

NeuroMedix Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore NeuroMedix‘s full profile, request access.

Request full access to PitchBook

NeuroMedix Executive Team (2)

Name Title Board
Seat
Contact
Info
Mark Pearson Ph.D Chief Executive Officer
Catherine Auld Chief Financial Officer